Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization.

DiSesa VJ, Huval W, Lelcuk S, Jonas R, Maddi R, Lee-Son S, Shemin RJ, Collins JJ, Hechtman HB, Cohn LH. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization. Ann Thorac Surg. 1984 Nov; 38(5):514-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.